1-6 of 6
Erel Joffe
Close
Sort by
Journal Articles

Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study

Clinical Trials & Observations
Bradley Haverkos, Onder Alpdogan, Robert Baiocchi, Jonathan E. Brammer, Tatyana A. Feldman, Marcelo Capra, Elizabeth A. Brem, Santosh Nair, Phillip Scheinberg, Juliana Pereira, Leyla Shune, Erel Joffe, Patricia Young, Susan Spruill, Afton Katkov, Robert McRae, Ivor Royston, Douglas V. Faller, Lisa Rojkjaer, Pierluigi Porcu
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6339–6350.
https://doi.org/10.1182/bloodadvances.2023010330
Published: 2023
Includes: Supplemental data
Journal Articles

Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study

Shunan Qi, Xin Liu, Ariela Noy, Jisun Lee, Sewit Teckie, Carla Hajj, Erel Joffe, Brandon S. Imber, Joachim Yahalom
Journal: Blood Advances
Blood Adv (2023) 7 (8): 1496–1506.
https://doi.org/10.1182/bloodadvances.2022007772
Published: 2023
Includes: Supplemental data
Journal Articles

Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?

Clinical Trials & Observations
Brandon S. Imber, Karen W. Chau, Jasme Lee, Jisun Lee, Dana L. Casey, Joanna C. Yang, N. Ari Wijentunga, Annemarie Shepherd, Carla Hajj, Shunan Qi, Monica R. Chelius, Paul A. Hamlin, M. Lia Palomba, Erel Joffe, Zhigang Zhang, Andrew D. Zelenetz, Gilles A. Salles, Joachim Yahalom
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4185–4197.
https://doi.org/10.1182/bloodadvances.2021004939
Published: 2021
Includes: Supplemental data
Journal Articles

Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue

Clinical Trials & Observations
Erel Joffe, Yan Leyfman, Esther Drill, Sridevi Rajeeve, Andrew D. Zelenetz, M. Lia Palomba, Craig H. Moskowitz, Carol Portlock, Ariela Noy, Steven M. Horwitz, John F. Gerecitano, Alison Moskowitz, Paul Hamlin, Matthew J. Matasar, Anita Kumar, Connie L. Batlevi, Anas Younes, David J. Straus
Journal: Blood Advances
Blood Adv (2021) 5 (2): 345–351.
https://doi.org/10.1182/bloodadvances.2020003213
Published: 2021
Journal Articles

Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies

Clinical Trials & Observations
David Sermer, Connie Batlevi, M. Lia Palomba, Gunjan Shah, Richard J. Lin, Miguel-Angel Perales, Michael Scordo, Parastoo Dahi, Martina Pennisi, Aishat Afuye, Mari Lynne Silverberg, Caleb Ho, Jessica Flynn, Sean Devlin, Philip Caron, Audrey Hamilton, Paul Hamlin, Steven Horwitz, Erel Joffe, Anita Kumar, Matthew Matasar, Ariela Noy, Colette Owens, Alison Moskowitz, David Straus, Gottfried von Keudell, Ildefonso Rodriguez-Rivera, Lorenzo Falchi, Andrew Zelenetz, Joachim Yahalom, Anas Younes, Craig Sauter
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4669–4678.
https://doi.org/10.1182/bloodadvances.2020002118
Published: 2020
Includes: Supplemental data
Journal Articles

Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
David Sermer, Sabela Bobillo, Ahmet Dogan, Yanming Zhang, Venkatraman Seshan, Jessica A. Lavery, Connie Batlevi, Philip Caron, Audrey Hamilton, Paul Hamlin, Steven Horwitz, Erel Joffe, Anita Kumar, Matthew Matasar, Ariela Noy, Colette Owens, Alison Moskowitz, M. Lia Palomba, David Straus, Gottfried von Keudell, Ildefonso Rodriguez-Rivera, Lorenzo Falchi, Andrew Zelenetz, Joachim Yahalom, Anas Younes
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3382–3390.
https://doi.org/10.1182/bloodadvances.2020001551
Published: 2020
Includes: Supplemental data